Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study
Clinical trial NCT04233372 · COMPLETED
Trial details
- NCT number
- NCT04233372
- Sponsor
- Hospital Clinic of Barcelona
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-27
- Primary completion
- 2022-07-28
- Enrollment
- 399
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.